Jean-Pierre Issa of Temple’s Fels Institute for Cancer says thanks to funding from Stand Up to Cancer, he is working on groundbreaking research on epigenetics. Instead of killing cancer cells with traditional chemotherapy, which causes side effects, epigenetics aims to re-train cancer cells to act normally. "We have seen enough good results in some patients, in fact spectacular results in a few patients, that we are excited about this therapy," Issa said.